Lullaby Project for Aura

Phase-Based Progress Estimates
University Health Network, Toronto, Canada
Aura+1 More
Lullaby Project - Behavioral
What conditions do you have?

Study Summary

This study's proposed intervention is the randomized participation of pregnant individuals with epilepsy in the Lullaby Project coordinated by The Corporation of Massey Hall and Roy Thomson Hall (MH-RTH) in Toronto. The purpose of this present study is to investigate the potential benefits of the Lullaby Project on pregnant individuals with epilepsy. Namely, effects on quality of life related to epilepsy, symptoms of depression and anxiety, perceived stress, and feelings of empowerment.

Eligible Conditions

  • Pregnancy Related
  • Aura

Treatment Effectiveness

Effectiveness Progress

1 of 3

Other trials for Aura

Study Objectives

1 Primary · 2 Secondary · Reporting Duration: 6 months

6 months
Depression and Anxiety
Pregnancy-related Empowerment
Quality of Life in Epilepsy

Trial Safety

Safety Progress

1 of 3

Other trials for Aura

Trial Design

2 Treatment Groups

1 of 2
Lullaby Project
1 of 2
Active Control

30 Total Participants · 2 Treatment Groups

Primary Treatment: Lullaby Project · No Placebo Group · N/A

ControlNoIntervention Group · 1 Intervention: Control · Intervention Types:
Lullaby Project
ActiveComparator Group · 1 Intervention: Lullaby Project · Intervention Types: Behavioral

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 6 months
Closest Location: University Health Network · Toronto, Canada
Photo of Toronto 1Photo of Toronto 2Photo of Toronto 3
2005First Recorded Clinical Trial
0 TrialsResearching Aura
272 CompletedClinical Trials

Who is running the clinical trial?

University Health Network, TorontoLead Sponsor
1,351 Previous Clinical Trials
471,603 Total Patients Enrolled

Eligibility Criteria

Age 18+ · Female Participants · 5 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You are at least 18 years old.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.